NAACCR 2016-2017 Webinar Series Collecting Cancer Data: Melanoma Part 1

Corry

Marketing Manager

FROM THE CANSWER FORUM:

NAACCR WEBINAR 2016-2017 SERIES: Collecting Cancer Data:  Melanoma Part 1 – MP/H Rules

Multiple Primary & Histology Rules

  • M3: Topography codes different at second (Cxx.x), third
  • (Cxx.x) or Fourth character (Cxx.x) are multiple primaries
    • EX: Patient has invasive melanoma on right leg (C44.7) and an invasive melanoma on right arm (C44.6)
  • M4: Different laterality are multiple primaries
    • EX: Patient has invasive melanoma on right trunk (C44.5) and an invasive melanoma on midline trunk (C44.5)
    • Webinar Q&A: Q: Will you be discussing later about laterality for C44.4 & MPH rules?   A: Yes.  C444, C448 and C449 are not paired sites.  Rule M4 for melanoma only applies to paired sites.  
  • M5: Histology codes different at first (xxxx), second (xxxx) or third number(xxxx) are multiple primaries
    • EX: Patient has invasive melanoma (8720/3)on right leg (C44.7) and another invasive superficial spreading melanoma (8743/3) on right leg (C44.7)
  • H5: Code histologic type when diagnosis is regressing melanoma and a histologic type
    • Webinar Q&A: Q: Will you please give an example of rule H5?
    • A: Nodular melanoma with features of regression would be coded to Nodular melanoma Code 8721.  This is the example used in the MPH rules pg. 297.
  • H6: Code 8723 (malignant melanoma, regressing) when diagnosis is regressing melanoma
    • Webinar Q&A: Q: Melanoma with features of regression — is this 8723?
    • A: Yes. The example they use in the MPH for rule H6 is this exact example.  (MPH pg. 297)
  • H7: Code histologic type when diagnosis is lentigo maligna melanoma and a histologic type
    • Webinar Q&A: Q: Also will you give an example of rule H7?
    • A: nodular lentigo maligna melanoma, you would code to nodular melanoma (8721).
  • H8: Code 8742 (lentigo maligna melanoma) when the diagnosis is lentigo maligna melanoma
  • H9: Code most specific histology term: melanoma, NOS with a single specific type
    • In situ lesions: Pattern, architecture, type, subtype, predominantly, with features of , major or with ___ differentiation
    • Invasive lesions: Type, subtype, predominantly, with features of , major or with ___ differentiation